White Pine Capital LLC continued to hold its stake in shares of Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,060 shares of the company’s stock at the end of the second quarter. White Pine Capital LLC’s holdings in Colgate-Palmolive were worth $449,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Blue Chip Partners Inc. increased its holdings in shares of Colgate-Palmolive by 0.4% during the 1st quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after purchasing an additional 8 shares during the period. Cue Financial Group Inc. increased its holdings in shares of Colgate-Palmolive by 0.3% during the 2nd quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after purchasing an additional 14 shares during the period. Cornerstone Financial Partners LLC increased its holdings in shares of Colgate-Palmolive by 0.5% during the 2nd quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after purchasing an additional 19 shares during the period. M Holdings Securities Inc. increased its holdings in shares of Colgate-Palmolive by 0.4% during the 1st quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after purchasing an additional 21 shares during the period. Finally, AlphaMark Advisors LLC increased its holdings in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. Hedge funds and other institutional investors own 73.87% of the company’s stock.
CL has been the topic of several research reports. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Jefferies Group LLC restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a report on Tuesday, October 31st. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Finally, Macquarie initiated coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $76.67.
Colgate-Palmolive Company (NYSE:CL) opened at $73.70 on Tuesday. The company has a market cap of $64,286.08, a PE ratio of 25.51, a price-to-earnings-growth ratio of 3.35 and a beta of 0.80. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 earnings per share. equities research analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.17%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
In other news, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the transaction, the chief marketing officer now directly owns 45,217 shares in the company, valued at $3,313,501.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the transaction, the insider now owns 60,528 shares in the company, valued at $4,422,780.96. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 164,673 shares of company stock worth $11,968,603. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.